Midostaurin in Adults with Newly Diagnosed FLT3-Mutation-Positive Acute Myeloid Leukemia Eligible for Standard Chemotherapy: Update from the Radius-X Midostaurin Expanded Access Program Article
Full Text via DOI: 10.1182/blood-2018-99-113608
Web of Science: 000454842803074
Industry Collaboration